# Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion

> **NCT02338648** · PHASE2 · COMPLETED · sponsor: **Senju USA, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Chalazion

## Interventions

- **DRUG:** SUN-131 1.5% TDS
- **DRUG:** Placebo TDS

## Key facts

- **NCT ID:** NCT02338648
- **Lead sponsor:** Senju USA, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2017-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02338648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02338648, "Safety and Efficacy Study of SUN 131 TDS as Compared to Placebo TDS in Adult Patients With a Chalazion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02338648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*